Loading...
XNASPDCO
Market cap2.72bUSD
Jan 10, Last price  
30.81USD
1D
-0.13%
1Q
49.27%
Jan 2017
-24.91%
Name

Patterson Companies Inc

Chart & Performance

D1W1MN
XNAS:PDCO chart
P/E
14.63
P/S
0.41
EPS
2.11
Div Yield, %
3.62%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
3.34%
Revenues
6.57b
+1.50%
2,421,457,0002,615,123,0002,798,398,0002,998,729,0003,094,227,0003,237,376,0003,415,670,0003,535,661,0003,637,212,0004,063,715,0004,375,020,0005,386,703,0005,593,127,0005,465,683,0005,574,523,0005,490,011,0005,912,066,0006,499,405,0006,471,471,0006,568,272,000
Net income
186m
-10.42%
183,698,000198,425,000208,336,000224,858,000199,635,000212,254,000225,385,000212,815,000210,272,000200,612,000223,261,000187,184,000170,893,000200,974,00083,628,000-589,367,000155,981,000203,210,000207,557,000185,931,000
CFO
-789m
L+4.57%
207,305,000163,958,000243,505,000265,379,000124,005,000265,485,000262,612,000321,158,000299,195,000195,793,000262,691,000156,329,000162,719,000178,895,00048,158,000-243,544,000-730,519,000-980,994,000-754,852,000-789,378,000
Dividend
Oct 18, 20240.26 USD/sh
Earnings
Feb 26, 2025

Profile

Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
IPO date
Sep 01, 1992
Employees
7,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑042015‑04
Income
Revenues
6,568,272
1.50%
6,471,471
-0.43%
6,499,405
9.93%
Cost of revenue
5,188,030
5,107,594
5,217,585
Unusual Expense (Income)
NOPBT
1,380,242
1,363,877
1,281,820
NOPBT Margin
21.01%
21.08%
19.72%
Operating Taxes
57,534
63,563
64,540
Tax Rate
4.17%
4.66%
5.04%
NOPAT
1,322,708
1,300,314
1,217,280
Net income
185,931
-10.42%
207,557
2.14%
203,210
30.28%
Dividends
(98,333)
(101,346)
(101,111)
Dividend yield
4.07%
3.82%
3.34%
Proceeds from repurchase of equity
(229,508)
(55,492)
(35,000)
BB yield
9.51%
2.09%
1.15%
Debt
Debt current
341,565
109,390
58,348
Long-term debt
546,654
614,373
604,566
Deferred revenue
(119,143)
Other long-term liabilities
141,075
37,529
31,026
Net debt
607,437
404,072
381,718
Cash flow
Cash from operating activities
(789,378)
(754,852)
(980,994)
CAPEX
(67,626)
(64,220)
(38,308)
Cash from investing activities
959,543
901,567
1,239,028
Cash from financing activities
(215,905)
(126,484)
(253,234)
FCF
1,295,780
1,166,099
1,219,407
Balance
Cash
114,462
159,669
142,014
Long term investments
166,320
160,022
139,182
Excess cash
Stockholders' equity
743,053
885,829
842,115
Invested Capital
1,905,747
1,829,061
1,663,895
ROIC
70.83%
74.45%
71.87%
ROCE
72.43%
70.01%
71.84%
EV
Common stock shares outstanding
93,679
97,815
98,514
Price
25.77
-4.94%
27.11
-11.89%
30.77
-8.04%
Market cap
2,414,108
-8.96%
2,651,765
-12.52%
3,031,276
-6.28%
EV
3,022,133
3,057,837
3,413,953
EBITDA
1,468,398
1,447,581
1,363,812
EV/EBITDA
2.06
2.11
2.50
Interest
44,910
33,636
20,288
Interest/NOPBT
3.25%
2.47%
1.58%